Novartis’s Global Drug Development (GDD) organization oversees all drug development activities for its Innovative Medicines division (Pharmaceuticals and Oncology) and the Sandoz division’s biosimilar portfolio.
GDD works collaboratively with the Novartis Institutes of Biomedical Research (NIBR) and Novartis’ customer facing business units to execute the company’s overall research and development strategy.
GDD represents approximately 11,000 associates worldwide.
To continue to add even greater value for the business, we need to have the right people with the right capabilities in the right location.
We need to be customer-oriented and focus on bringing the best services and solutions to the business both globally and locally to support our patients.
Novartis GDD offers an extraordinary work experience with a real opportunity to develop in a highly fast-paced technology-
driven environment where collaboration and innovation are at the heart of who we are and what we do.
Job purpose :
As a CRA in Global Drug Development (GDD), you will :
IV Oncology and Pharma clinical trials within the country,
Job requirements :
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs : innovative medicines, cost-
saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas.
In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.
0 billion. Novartis Group companies employ approximately 125,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
For more information, please visit http : / / www.novartis.com
Submit your application until Monday 15.10.2018